Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea
Clinical trial NCT02498418 · COMPLETED
Trial details
- NCT number
- NCT02498418
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-06
- Primary completion
- 2017-02-28
- Enrollment
- 739
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.